INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

71,123 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
2,500 sh
Nov 2, 2026
Page 117 of 1779
← PrevNext →
Nov 4, 2026
traded Nov 2, 2026
+2d
SEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
6,250 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
3,500 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
5,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
100.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Derivative conversion
C$526K
24.7K sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

8
SB
Sousa Mauad BrunoDirector
AUGOAura Minerals Inc.
Derivative conversion
C$526K
24.7K sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

8
TD
Tsao DavidDirector, Chief Technology Officer
BLLNBillionToOne, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
100 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
20.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
SB
Sensenig BethanyDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
8,252 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
SB
Sensenig BethanyDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
24.2K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
BG
Baszucki GregoryDirector
RBLXRoblox Corp
Open-market sale · 10b5-1 plan
SELL$140K
3,048 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
13.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
BG
Baszucki GregoryDirector
RBLXRoblox Corp
Open-market sale · 10b5-1 plan
SELL$204K
4,485 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

8
BG
Baszucki GregoryDirector
RBLXRoblox Corp
Open-market sale · 10b5-1 plan
SELL$204K
4,481 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

8
HT
Hall John TDirector, Chief Executive Officer
INTAIntapp, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
300 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
SB
Sensenig BethanyDirector
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
2,989 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
CG
Clark Joseph GatesSVP and Pres, Optimized LED
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$49K
1,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
CG
Clark Joseph GatesSVP and Pres, Optimized LED
PENGPenguin Solutions, Inc.
Open-market sale · 10b5-1 plan
SELL$46K
900 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
WS
Wampler Kira SchererDirector
DOCSDoximity, Inc.
Open-market sale · 10b5-1 plan
SELL$66K
2,000 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

8
HT
Horich William ToddSVP, Commercial Operations
SUPNSUPERNUS PHARMACEUTICALS, INC.
Other acquisition or disposition
J—
25.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

7
TS
Tang StanleyDirector
DASHDoorDash, Inc.
Other acquisition or disposition · 10b5-1 plan
J—
23.1K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

7
ZR
Zage George Raymond IIIDirector, 10% Owner
GRNDGrindr Inc.
Open-market sale · 10b5-1 plan
SELL$2.22M
170.0K sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

7
CJ
Comly Barbara J.EVP, GC & Corporate Secretary
MIAXMIAMI INTERNATIONAL HOLDINGS, INC.
Option exercise · 10b5-1 plan
M—
47.2K sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

7
TR
Tsuchimoto Kim RDirector
MNPRMonopar Therapeutics
Option exercise · 10b5-1 plan
M—
2,035 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

7
BL
Bayview Legacy, LLC10% Owner
AIPArteris, Inc.
Open-market sale · 10b5-1 plan
SELL$1.73M
95.1K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

7
TR
Tsuchimoto Kim RDirector
MNPRMonopar Therapeutics
Option exercise · 10b5-1 plan
M—
1,199 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

7
MJ
Maetzold Derek JDirector, Pres. & Chief Exec. Officer
CSTLCASTLE BIOSCIENCES INC
Open-market sale · 10b5-1 plan
SELL$12K
325 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

7
MJ
Maetzold Derek JDirector, Pres. & Chief Exec. Officer
CSTLCASTLE BIOSCIENCES INC
Open-market sale · 10b5-1 plan
SELL$14K
382 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

7
WY
Wassenaar YvonneDirector
RBRKRubrik, Inc.
Derivative conversion · 10b5-1 plan
C—
721 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

7
AR
Anderson RaymondDirector
MNPRMonopar Therapeutics
Option exercise · 10b5-1 plan
M$42K
1,402 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

7
ZR
Zage George Raymond IIIDirector, 10% Owner
GRNDGrindr Inc.
Open-market sale · 10b5-1 plan
SELL$4.22M
330.0K sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

7
TR
Tsuchimoto Kim RDirector
MNPRMonopar Therapeutics
Option exercise · 10b5-1 plan
M$28K
2,035 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

6
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$160K
1,375 sh
Nov 4, 2026Nov 4, 2026
traded Nov 4, 2026
+0dSEC Form 4

Evidence

6
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$100K
399 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

6
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$139K
565 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

6
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$192K
774 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

6
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Open-market sale · 10b5-1 plan
SELL$123K
1,064 sh
Nov 3, 2026Nov 4, 2026
traded Nov 3, 2026
+1dSEC Form 4

Evidence

6
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$183K
747 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence

6
Kurtz GeorgeDirector, PRESIDENT AND CEO
CRWDCrowdStrike Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$227K
933 sh
Nov 2, 2026Nov 4, 2026
traded Nov 2, 2026
+2dSEC Form 4

Evidence